SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-129579
Filing Date
2021-10-25
Accepted
2021-10-25 17:23:43
Documents
14
Period of Report
2021-10-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131001d1_8k.htm   iXBRL 8-K 30281
2 EXHIBIT 99.1 tm2131001d1_ex99-1.htm EX-99.1 12547
6 GRAPHIC tm2131001d1_ex99-1img01.jpg GRAPHIC 6336
  Complete submission text file 0001104659-21-129579.txt   231316

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA azyo-20211025.xsd EX-101.SCH 3016
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE azyo-20211025_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azyo-20211025_pre.xml EX-101.PRE 22353
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2131001d1_8k_htm.xml XML 3748
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 211345065
SIC: 2836 Biological Products, (No Diagnostic Substances)